DELRAY BEACH, Fla., Nov. 17, 2025 /PRNewswire/ -- The global Pharmaceutical Quality Management Software Market, valued at US$1.41 billion in 2024, stood at US$1.59 billion in 2025 and is projected to ...

Adoption of CRM to streamline clinical data coordination globally. Demand for compliance-focused CRM solutions in regulatory-intensive environments. Need for real-time data sharing to accelerate drug ...

Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences industries. Veeva is valued at over $20 billion and is considered a top player in the industry, ...

TAMPA, Fla.--(BUSINESS WIRE)--Pilgrim Software, Inc., a world-leading provider of Enterprise Risk, Compliance and Quality Management (ERCQM) software solutions, today announced that TOLMAR Inc., a ...

New Data from Sparta Systems Reveals Organizations Leveraging System Integrations to Ensure Manufacturing Incidents Do Not Impact Products on Market Forward-thinking pharmaceutical organizations that ...

WEST LAFAYETTE, Ind. — International process systems and operation experts have launched high-tech startup Crystallization Systems Technology Inc. (CrySyst) to streamline processes used by companies ...

PEMBROKE PINES, Fla.--(BUSINESS WIRE)--MDH Insight’s (MDH) game-changing in-house software EmpowerRM can be the best 2021 resolution embraced by small to mid-size generic pharma manufacturers that ...

Behind every successful product launch lies a meticulous process of trials, tests, and strategic planning. This journey is even more critical in medicine, as the stakes involve human lives and public ...

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process ...

According to data by Statista, the revenue of the worldwide pharmaceutical market at the end of 2020 was $1.27 trillion. The growth of this market is largely associated with information technologies.

Tom Hughes is the founder and CEO of Virtual Science AI. For companies seeking to upgrade their technology, the “build or buy” question—that is, whether to create purpose-built software in-house or ...